Find uplifting stories about heroes, innovations, and solutions
6368 results for "tuberculosis treatment"
Tuberculosis patients in Tanzania can now complete treatment in just six months instead of up to a year, thanks to a new WHO-approved regimen. The East African nation is leading the way in implementing the faster treatment approach, offering hope to thousands battling the infectious disease.
Bestselling author John Green is gifting exclusive poetry readings to people who buy coffee and tea that fights the world's deadliest infectious disease. Every purchase sends 100% of profits to get tuberculosis treatment to people who need it most.
Scientists developed a once-weekly inhaled tuberculosis treatment that delivers medicine straight to the lungs, potentially replacing months of daily pills that cause serious side effects. The breakthrough could help millions worldwide finish their TB treatment and prevent drug-resistant infections.
Researchers are asking tuberculosis patients what they need before developing a new long-acting injectable treatment. Their answers are already changing how drug makers approach the cure for a disease that killed 1.23 million people in 2024.
A hospital in Angola reduced tuberculosis treatment abandonment by nearly 20% through home visits and family support programs. The progress shows how community-based care can help patients complete life-saving treatment.
Nigeria's capital territory is winning the fight against tuberculosis with a remarkable 94% treatment success rate and a 64% drop in TB deaths. Despite reporting 16,000 cases annually, early detection and community outreach are turning the tide on this deadly disease.
Tanzanian researchers are testing new tuberculosis treatments that could slash recovery time from six months to just three, making it easier for patients to finish their medication. The breakthrough comes as Tanzania has already cut TB deaths by 59% since 2015.
Nigeria's Federal Capital Territory is saving lives at an unprecedented rate, curing 94% of tuberculosis patients through early detection and community care. TB deaths have dropped 64% as health workers bring free screening directly to neighborhoods.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
Showing 20 of 6368